160 related articles for article (PubMed ID: 17914336)
1. Proteomic approach to breast cancer.
Laronga C; Drake RR
Cancer Control; 2007 Oct; 14(4):360-8. PubMed ID: 17914336
[TBL] [Abstract][Full Text] [Related]
2. Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression.
Brozkova K; Budinska E; Bouchal P; Hernychova L; Knoflickova D; Valik D; Vyzula R; Vojtesek B; Nenutil R
Breast Cancer Res; 2008; 10(3):R48. PubMed ID: 18510725
[TBL] [Abstract][Full Text] [Related]
3. Fine Needle Aspiration Combined With Matrix-assisted Laser Desorption Ionization Time-of-Flight/Mass Spectrometry to Characterize Lipid Biomarkers for Diagnosing Accuracy of Breast Cancer.
Cho YT; Su H; Chiang YY; Shiea J; Yuan SF; Hung WC; Yeh YT; Hou MF
Clin Breast Cancer; 2017 Aug; 17(5):373-381.e1. PubMed ID: 28648841
[TBL] [Abstract][Full Text] [Related]
4. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
5. Cytologic findings and protein expression profiles associated with ductal carcinoma of the breast in ductal lavage specimens using surface-enhanced laser desorption and ionization-time of flight mass spectrometry.
Mendrinos S; Nolen JD; Styblo T; Carlson G; Pohl J; Lewis M; Ritchie J
Cancer; 2005 Jun; 105(3):178-83. PubMed ID: 15822128
[TBL] [Abstract][Full Text] [Related]
6. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.
Pietrowska M; Marczak L; Polanska J; Behrendt K; Nowicka E; Walaszczyk A; Chmura A; Deja R; Stobiecki M; Polanski A; Tarnawski R; Widlak P
J Transl Med; 2009 Jul; 7():60. PubMed ID: 19594898
[TBL] [Abstract][Full Text] [Related]
8. [Proteomics and breast cancer].
Mathelin C; Tomasetto C; Cromer A; Rio MC
Gynecol Obstet Fertil; 2006 Dec; 34(12):1161-9. PubMed ID: 17123853
[TBL] [Abstract][Full Text] [Related]
9. Detection of lung cancer using plasma protein profiling by matrix-assisted laser desorption/ionization mass spectrometry.
Shevchenko VE; Arnotskaya NE; Zaridze DG
Eur J Mass Spectrom (Chichester); 2010; 16(4):539-49. PubMed ID: 20625202
[TBL] [Abstract][Full Text] [Related]
10. Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors.
Ricolleau G; Charbonnel C; Lodé L; Loussouarn D; Joalland MP; Bogumil R; Jourdain S; Minvielle S; Campone M; Déporte-Fety R; Campion L; Jézéquel P
Proteomics; 2006 Mar; 6(6):1963-75. PubMed ID: 16470659
[TBL] [Abstract][Full Text] [Related]
11. Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid.
Li J; Zhao J; Yu X; Lange J; Kuerer H; Krishnamurthy S; Schilling E; Khan SA; Sukumar S; Chan DW
Clin Cancer Res; 2005 Dec; 11(23):8312-20. PubMed ID: 16322290
[TBL] [Abstract][Full Text] [Related]
12. Protein profiling for cancer biomarker discovery using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and infrared imaging: a review.
Bakry R; Rainer M; Huck CW; Bonn GK
Anal Chim Acta; 2011 Mar; 690(1):26-34. PubMed ID: 21414433
[TBL] [Abstract][Full Text] [Related]
13. [Application of serum proteomic mass spectrum analysis in breast cancer].
Ying MG; Chen Q; Ye YB; Chen HJ; Chen X; Zheng HY; Wu F
Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):698-702. PubMed ID: 21122387
[TBL] [Abstract][Full Text] [Related]
14. [Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers].
Solassol J; Marin P; Maudelonde T; Mangé A
Bull Cancer; 2005 Sep; 92(9):763-8. PubMed ID: 16203265
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of nipple aspirate fluid using SELDI-TOF-MS.
Sauter ER; Shan S; Hewett JE; Speckman P; Du Bois GC
Int J Cancer; 2005 May; 114(5):791-6. PubMed ID: 15609313
[TBL] [Abstract][Full Text] [Related]
16. Proteomic diagnosis competition: design, concepts, participants and first results.
Mertens BJ
J Proteomics; 2009 Jul; 72(5):785-90. PubMed ID: 19375529
[TBL] [Abstract][Full Text] [Related]
17. The importance of experimental design in proteomic mass spectrometry experiments: some cautionary tales.
Hu J; Coombes KR; Morris JS; Baggerly KA
Brief Funct Genomic Proteomic; 2005 Feb; 3(4):322-31. PubMed ID: 15814023
[TBL] [Abstract][Full Text] [Related]
18. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.
Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J
J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601
[TBL] [Abstract][Full Text] [Related]
19. [Proteic profiling SELDI-TOF and breast cancer: clinical potential applications].
Gonçalves A; Bertucci F; Birnbaum D; Borg JP
Med Sci (Paris); 2007 Mar; 23 Spec No 1():23-6. PubMed ID: 17669349
[TBL] [Abstract][Full Text] [Related]
20. Progress in proteomics for clinical microbiology: MALDI-TOF MS for microbial species identification and more.
van Belkum A; Chatellier S; Girard V; Pincus D; Deol P; Dunne WM
Expert Rev Proteomics; 2015; 12(6):595-605. PubMed ID: 26472137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]